Manuel S. Eisenberg
- Sep 14, 2020
- 1 min read

% free PSA after BioChemical Recurrence (BCR)

In patient's undergoing screening for prostate cancer with PSA, % free PSA can be used to further understand the risk of cancer. For PSA between 4 and 10, a low % free PSA (<25%) is considered favorable. A new study demonstrates that % free PSA after prostate removal can be helpful to determine risk as well. If the PSA starts to rise after prostate removal, a low % free PSA (<15%) indicates decreased risk of disease spread and other poor outcomes.

https://pubmed.ncbi.nlm.nih.gov/32125228/

Recent Posts

See All

Salvage radiation after prostate removal shows excellent cancer control and reduced complications

There is approximately a 25% risk of cancer coming back after prostatectomy for prostate cancer. The risk is elevated if worrisome features are seen on the pathology report such as positive margins,

MRI is becoming more useful in the detection of significant prostate cancer

Traditional imaging such as x-rays, ultrasound, and CT scans have limited ability to see into the prostate and find malignancy. MRI has provided the most useful detection of prostate cancer. As MRI te

Finasteride/Dutasteride do not make prostate cancer worse

Alpha reductase inhibitors (finasteride, dutasteride) help prevent growth of the prostate and worsening of urinary symptoms in men. Studies have shown that these medications can reduce the risk of de